Regulating insulin and leptin levels using a protein tyrosine phosphatase 1B (PTP1B) inhibitor is an attractive strategy to treat diabetes and obesity. This evidence concerns the gene PTPN1 and obesity due to melanocortin 4 receptor deficiency.